Maxalt
NDC 16590-461
Product Information
Maxalt is a NDA-approved product labeled by Stat Rx Usa Llc. Rizatriptan is used to treat migraines. It is supplied as a white product. This product entry covers the primary NDC 16590-461 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
PINK (C48328 - PALE PINK)
OVAL (C48345)
;
MAXALT;MRK;267
Code Structure Chart
Product Details
What is NDC 16590-461?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- RIZATRIPTAN BENZOATE (UNII: WR978S7QHH)
- RIZATRIPTAN (UNII: 51086HBW8G) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- GELATIN (UNII: 2G86QN327L)
- MANNITOL (UNII: 3OWL53L36A)
- GLYCINE (UNII: TE7660XO1C)
- ASPARTAME (UNII: Z0H242BBR1)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- STARCH, CORN (UNII: O8232NY3SJ)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 213322 - Maxalt 10 MG Oral Tablet
- RxCUI: 213322 - rizatriptan 10 MG Oral Tablet [Maxalt]
- RxCUI: 312839 - rizatriptan benzoate 5 MG Disintegrating Oral Tablet
- RxCUI: 312839 - rizatriptan 5 MG Disintegrating Oral Tablet
- RxCUI: 312839 - rizatriptan 5 MG (as rizatriptan benzoate 7.265 MG) Disintegrating Oral Tablet
* Please review the full disclaimer at the bottom of this page.